Noven Pharmaceuticals, Inc.
基本情報
- 所在地
- Miami, Florida and Jersey City, New Jersey, USA
- 社長
- Takeshi Masumoto
- 従業員数(単独)
- 300 人
- 従業員数(連結)
- 開始日
- 1987-01-01
- 終了日
サイト
事業内容
関連会社
| 会社名 | Group | 親会社 | 子会社 | 得意先 | 仕入先 | 業務提携 | 銀行等 | 株主等 |
|---|---|---|---|---|---|---|---|---|
| Hisamitsu Pharmaceutical Co., Inc. | ||||||||
| Noven Therapeutics, LLC | ||||||||
| Noven Therapeutics |
関連図
沿革
Launch of CombiPatch ® (estradiol/norethindrone acetate transdermal system), the first combination (two-drug) patch
Launch of Vivelle-Dot ® (estradiol transdermal system), the world's smallest estrogen patch at the time
Shire licenses Noven's Daytrana ® patch for ADHD
Shire and Noven launch Daytrana ®
Noven acquires JDS Pharmaceuticals, expanding its portfolio and sales capabilities
Noven acquired by Hisamitsu Pharmaceuticals; public company status concludes
Noven reacquires Daytrana
Hisamitsu Carlsbad facility integrated with Noven operations
Noven's Northeast operations consolidated in Empire State Building co-headquarters
Minivelle approved by FDA
Noven acquires Minivelle, establishes Women's Health sales team
Noven Women's Health team launches Minivelle
Brisdelle approved by the FDA
Launch of Brisdelle
Minivelle (Estradiol Transdermal System) 0.025 Mg/Day Dose Available By Prescription In U.S. Pharmacies. UPDATE: MINIVELLE has been removed from Market. ESTRADIOL TS, the authorized generic to MINIVELLE is available.
Brisdelle (paroxetine) and Pexeva (paroxetine) acquired by Sebela Pharmaceuticals
SECUADO (asenapine) transdermal system FDA approval
Launch of SECUADO
Approval of XELSTRYM
Launch of XELSTRYM
ニュース
ニュースはありません。